Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 2985-2998

  Leonhardt, Ralf M ^a   Fiegl, Dorothee ^b   Rufer, Elke ^b   Karger, Axel ^b   Bettin, Barbara ^b   Knittler, Michael R ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROPROTEIN CONVERTASE PC7; SERINE PROTEINASE; UNCLASSIFIED DRUG; ENZYME PRECURSOR; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA BW51; HLA-BW51; PEPTIDE; SUBTILISIN;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUALITY CONTROL; SURFACE PROPERTY; T LYMPHOCYTE; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; CELL LINE; CELL STRAIN HEPG2; CYTOPLASM VESICLE; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; GOLGI COMPLEX; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RAT; RNA INTERFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CELL LINE, TRANSFORMED; CYTOPLASMIC VESICLES; ENDOPLASMIC RETICULUM; ENZYME PRECURSORS; GOLGI APPARATUS; HEP G2 CELLS; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RATS; RNA INTERFERENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBTILISINS;

EID: 77951927648     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900308     Document Type: Article

References (65)

1. Wright, C. A., P. Kozik, M. Zacharias, and S. Springer. 2004. Tapasin and other chaperones: models of the MHC class I loading complex. Biol. Chem. 385: 763-778.
2. Tan, P., H. Kropshofer, O. Mandelboim, N. Bulbuc, G. J. Hämmerling, and F. Momburg. 2002. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading. J. Immunol. 168: 1950-1960. (Pubitemid 34135798)
3. Leonhardt, R. M., K. Keusekotten, C. Bekpen, and M. R. Knittler. 2005. Critical role for the tapasin-docking site of TAP2 in the functional integrity of the MHC class I-peptide-loading complex. J. Immunol. 174: 5104-5114.
4. Williams, A. P., C. A. Peh, A. W. Purcell, J. McCluskey, and T. Elliott. 2002. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520.
5. Park, B., Y. Kim, J. Shin, S. Lee, K. Cho, K. Früh, S. Lee, and K. Ahn. 2004. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85. (Pubitemid 38134295)
6. Park, B., S. Lee, E. Kim, K. Cho, S. R. Riddell, S. Cho, and K. Ahn. 2006. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127: 369-382. (Pubitemid 44572373)
7. Kim, Y., B. Park, S. Cho, J. Shin, K. Cho, Y. Jun, and K. Ahn. 2008. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. PLoS Pathog. 4: e1000123.
8. Gil-Torregrosa, B. C., A. R. Castaño, D. López, and M. Del Val. 2000. Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic 1: 641-651.
9. Tiwari, N., N. Garbi, T. Reinheckel, G. Moldenhauer, G. J. Hämmerling, and F. Momburg. 2007. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J. Immunol. 178: 7932-7942.
10. Seidah, N. G., R. Day, M. Marcinkiewicz, and M. Chrétien. 1998. Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. N. Y. Acad. Sci. 839: 9-24.
11. Khatib, A. M., G. Siegfried, M. Chrétien, P. Metrakos, and N. G. Seidah. 2002. Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am. J. Pathol. 160: 1921-1935.
12. Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3: 753-766.
13. Garten, W., S. Hallenberger, D. Ortmann, W. Schäfer, M. Vey, H. Angliker, E. Shaw, and H. D. Klenk. 1994. Processing of viral glycoproteins by the subtilisin- like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie 76: 217-225. (Pubitemid 24295536)
14. Rufer, E., R. M. Leonhardt, and M. R. Knittler. 2007. Molecular architecture of the TAP-associated MHC class I peptide-loading complex. J. Immunol. 179: 5717-5727.
15. DeMars, R., C. C. Chang, S. Shaw, P. J. Reitnauer, and P. M. Sondel. 1984. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum. Immunol. 11: 77-97.
16. Knittler, M. R., P. Alberts, E. V. Deverson, and J. C. Howard. 1999. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules. Curr. Biol. 9: 999-1008.
17. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 497-499.
18. Momburg, F., V. Ortiz-Navarrete, J. Neefjes, E. Goulmy, Y. van de Wal, H. Spits, S. J. Powis, G. W. Butcher, J. C. Howard, P. Walden, et al. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360: 174-177.
19. Powis, S. J., A. R. Townsend, E. V. Deverson, J. Bastin, G. W. Butcher, and J. C. Howard. 1991. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter. Nature 354: 528-531.
20. Lutz, P. M., and P. Cresswell. 1987. An epitope common to HLA class I and class II antigens, Ig light chains, and beta 2-microglobulin. Immunogenetics 25: 228-233.
21. Trapani, J. A., S. Mizuno, S. H. Kang, S. Y. Yang, and B. Dupont. 1989. Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody. Immunogenetics 29: 25-32.
22. Otsu, M., R. Urade, M. Kito, F. Omura, and M. Kikuchi. 1995. A possible role of ER-60 protease in the degradation of misfolded proteins in the endoplasmic reticulum. J. Biol. Chem. 270: 14958-14961.
23. Wouters, S., M. Leruth, E. Decroly, M. Vandenbranden, J. W. Creemers, J. W. van de Loo, J. M. Ruysschaert, and P. J. Courtoy. 1998. Furin and proprotein convertase 7 (PC7)/lymphoma PC endogenously expressed in rat liver can be resolved into distinct post-Golgi compartments. Biochem. J. 336: 311-316. (Pubitemid 28564386)
24. Fugere, M., J. Appel, R. A. Houghten, I. Lindberg, and R. Day. 2007. Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences. Mol. Pharmacol. 71: 323-332.
25. Batalia, M. A., T. J. Kirksey, A. Sharma, L. Jiang, J. P. Abastado, S. Yan, R. Zhao, and E. J. Collins. 2000. Class I MHC is stabilized against thermal denaturation by physiological concentrations of NaCl. Biochemistry 39: 9030-9038.
26. Remacle, A. G., S. A. Shiryaev, E. S. Oh, P. Cieplak, A. Srinivasan, G. Wei, R. C. Liddington, B. I. Ratnikov, A. Parent, R. Desjardins, et al. 2008. Substrate cleavage analysis of furin and related proprotein convertases. A comparative study. J. Biol. Chem. 283: 20897-20906.
27. Sorem, J., and R. Longnecker. 2009. Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J. Gen. Virol. 90: 591-595.
28. Duckert, P., S. Brunak, and N. Blom. 2004. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 17: 107-112.
29. Okazaki, K. 2007. Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus. J. Gen. Virol. 88: 1859-1865.
30. Rammensee, H., J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanović. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50: 213-219. (Pubitemid 30099526)
31. Kibler, K. V., A. Miyazato, V. S. Yedavalli, A. I. Dayton, B. L. Jacobs, G. Dapolito, S. J. Kim, and K. T. Jeang. 2004. Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. J. Biol. Chem. 279: 49055-49063.
32. Day, P. M., J. W. Yewdell, A. Porgador, R. N. Germain, and J. R. Bennink. 1997. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc. Natl. Acad. Sci. U.S.A. 94: 8064-8069.
33. Luft, T., M. Rizkalla, T. Y. Tai, Q. Chen, R. I. MacFarlan, I. D. Davis, E. Maraskovsky, and J. Cebon. 2001. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation. J. Immunol. 167: 2529-2537.
34. Brophy, S. E., L. L. Jones, P. D. Holler, and D. M. Kranz. 2007. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Mol. Immunol. 44: 2184-2194.
35. Liu, T., B. Chambers, A. D. Diehl, L. Van Kaer, M. Jondal, and H. G. Ljunggren. 1997. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells. J. Immunol. 159: 5364-5371. (Pubitemid 127470063)
36. Liu, T., X. Zhou, U. M. Abdel-Motal, H. G. Ljunggren, and M. Jondal. 1997. MHC class I presentation of live and heat-inactivated Sendai virus antigen in T2Kb cells depends on an intracellular compartment with endosomal characteristics. Scand. J. Immunol. 45: 527-533.
37. Zhou, X., T. Liu, L. Franksson, E. Lederer, H. G. Ljunggren, and M. Jondal. 1995. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes. Scand. J. Immunol. 42: 66-75.
38. Chefalo, P. J., and C. V. Harding. 2001. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH. J. Immunol. 167: 1274-1282.
39. Bennett, D. L., E. M. Bailyes, E. Nielsen, P. C. Guest, N. G. Rutherford, S. D. Arden, and J. C. Hutton. 1992. Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. J. Biol. Chem. 267: 15229-15236.
40. Chefalo, P. J., A. G. Grandea, 3rd, L. Van Kaer, and C. V. Harding. 2003. Tapasin -/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH. J. Immunol. 170: 5825-5833.
41. Grommé, M., F. G. Uytdehaag, H. Janssen, J. Calafat, R. S. van Binnendijk, M. J. Kenter, A. Tulp, D. Verwoerd, and J. Neefjes. 1999. Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. U.S.A. 96: 10326-10331.
42. Stryhn, A., L. O. Pedersen, T. Romme, A. C. Olsen, M. H. Nissen, C. J. Thorpe, and S. Buus. 1996. pH dependence of MHC class I-restricted peptide presentation. J. Immunol. 156: 4191-4197. (Pubitemid 26165815)
43. Gil-Torregrosa, B. C., A. Raúl Castaño, and M. Del Val. 1998. Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin. J. Exp. Med. 188: 1105-1116.
44. Lu, J., P. J. Wettstein, Y. Higashimoto, E. Appella, and E. Celis. 2001. TAP-independent presentation of CTL epitopes by Trojan antigens. J. Immunol. 166: 7063-7071. (Pubitemid 32525575)
45. Zhang, Y., Y. Kida, K. Kuwano, Y. Misumi, Y. Ikehara, and S. Arai. 2001. Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein. Microbiol. Immunol. 45: 119-125.
46. Walker, J. A., S. S. Molloy, G. Thomas, T. Sakaguchi, T. Yoshida, T. M. Chambers, and Y. Kawaoka. 1994. Sequence specificity of furin, a proprotein- processing endoprotease, for the hemagglutinin of a virulent avian in- fluenza virus. J. Virol. 68: 1213-1218.
47. Basak, A., M. Zhong, J. S. Munzer, M. Chrétien, and N. G. Seidah. 2001. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides. Biochem. J. 353: 537-545.
48. Messageot, F., S. Salhi, P. Eon, and J. M. Rossignol. 2003. Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences. J. Biol. Chem. 278: 891-895.
49. Johnstone, C., P. de León, F. Medina, J. A. Melero, B. García-Barreno, and M. Del Val. 2004. Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus. J. Gen. Virol. 85: 3229-3238.
50. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162: 5049-5052.
51. Berson, J. F., A. C. Theos, D. C. Harper, D. Tenza, G. Raposo, and M. S. Marks. 2003. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161: 521-533.
52. Scamuffa, N., G. Siegfried, Y. Bontemps, L. Ma, A. Basak, G. Cherel, F. Calvo, N. G. Seidah, and A. M. Khatib. 2008. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J. Clin. Invest. 118: 352-363.
53. Luckey, C. J., J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 2001. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167: 1212-1221.
54. Hammer, G. E., F. Gonzalez, E. James, H. Nolla, and N. Shastri. 2007. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8: 101-108.
55. Firat, E., J. Huai, L. Saveanu, S. Gaedicke, P. Aichele, K. Eichmann, P. van Endert, and G. Niedermann. 2007. Analysis of direct and cross-presentation of antigens in TPPII knockout mice. J. Immunol. 179: 8137-8145.
56. Towne, C. F., I. A. York, J. Neijssen, M. L. Karow, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, J. J. Neefjes, and K. L. Rock. 2005. Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation. J. Immunol. 175: 6605-6614.
57. Towne, C. F., I. A. York, J. Neijssen, M. L. Karow, A. J. Murphy, D. M. Valenzuela, G. D. Yancopoulos, J. J. Neefjes, and K. L. Rock. 2008. Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections. J. Immunol. 180: 1704-1712.
58. York, I. A., A. X. Mo, K. Lemerise, W. Zeng, Y. Shen, C. R. Abraham, T. Saric, A. L. Goldberg, and K. L. Rock. 2003. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18: 429-440.
59. Towne, C. F., I. A. York, L. B. Watkin, J. S. Lazo, and K. L. Rock. 2007. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses. J. Immunol. 178: 6923-6930.
60. Khatib, A. M., G. Siegfried, A. Prat, J. Luis, M. Chrétien, P. Metrakos, and N. G. Seidah. 2001. Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J. Biol. Chem. 276: 30686-30693.
61. Orci, L., M. Ravazzola, M. Amherdt, O. Madsen, A. Perrelet, J. D. Vassalli, and R. G. Anderson. 1986. Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J. Cell Biol. 103: 2273-2281.
62. Falk, K., O. Rötzschke, M. Takiguchi, V. Gnau, S. Stevanović, G. Jung, and H. G. Rammensee. 1995. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. Int. Immunol. 7: 223-228.
63. Reznik, S. E., and L. D. Fricker. 2001. Carboxypeptidases from A to z: implications in embryonic development and Wnt binding. Cell. Mol. Life Sci. 58: 1790-1804.
64. Harding, C. V. 1996. Class I MHC presentation of exogenous antigens. J. Clin. Immunol. 16: 90-96.
65. Marcinkiewicz, M., J. Marcinkiewicz, A. Chen, F. Leclaire, M. Chrétien, and P. Richardson. 1999. Nerve growth factor and proprotein convertases furin and PC7 in transected sciatic nerves and in nerve segments cultured in conditioned media: their presence in Schwann cells, macrophages, and smooth muscle cells. J. Comp. Neurol. 403: 471-485.